168 related articles for article (PubMed ID: 29285751)
21. Puerarin improves methotrexate-induced renal damage by up-regulating renal expression of Oat1 and Oat3 in vivo and in vitro.
Liu Q; Liu Z; Huo X; Wang C; Meng Q; Sun H; Sun P; Peng J; Ma X; Liu K
Biomed Pharmacother; 2018 Jul; 103():915-922. PubMed ID: 29710508
[TBL] [Abstract][Full Text] [Related]
22. Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging.
Nassif A; Jia J; Keiser M; Oswald S; Modess C; Nagel S; Weitschies W; Hosten N; Siegmund W; Kühn JP
Radiology; 2012 Sep; 264(3):741-50. PubMed ID: 22771883
[TBL] [Abstract][Full Text] [Related]
23. Investigation of Endogenous Compounds Applicable to Drug-Drug Interaction Studies Involving the Renal Organic Anion Transporters, OAT1 and OAT3, in Humans.
Tsuruya Y; Kato K; Sano Y; Imamura Y; Maeda K; Kumagai Y; Sugiyama Y; Kusuhara H
Drug Metab Dispos; 2016 Dec; 44(12):1925-1933. PubMed ID: 27638508
[TBL] [Abstract][Full Text] [Related]
24. Effects of single nucleotide polymorphisms and haplotypes of the SLCO1B1 gene on the pharmacokinetic profile of atorvastatin in healthy Macedonian volunteers.
Daka A; Dimovski A; Kapedanovska A; Vavlukis M; Eftimov A; Labachevski N; Jakjovski K; Geshkovska MN; Nebija D; Mladenovska K
Pharmazie; 2015 Jul; 70(7):480-8. PubMed ID: 26373210
[TBL] [Abstract][Full Text] [Related]
25. JBP485 improves gentamicin-induced acute renal failure by regulating the expression and function of Oat1 and Oat3 in rats.
Guo X; Meng Q; Liu Q; Wang C; Sun H; Peng J; Ma X; Kaku T; Liu K
Toxicol Appl Pharmacol; 2013 Sep; 271(2):285-95. PubMed ID: 23707770
[TBL] [Abstract][Full Text] [Related]
26. In vitro risk assessment of AZD9056 perpetrating a transporter-mediated drug-drug interaction with methotrexate.
Elsby R; Fox L; Stresser D; Layton M; Butters C; Sharma P; Smith V; Surry D
Eur J Pharm Sci; 2011 May; 43(1-2):41-9. PubMed ID: 21440623
[TBL] [Abstract][Full Text] [Related]
27. Association between SLCO1B1 polymorphism and methotrexate-induced hepatotoxicity: a systematic review and meta-analysis.
Han JM; Choi KH; Lee HH; Gwak HS
Anticancer Drugs; 2022 Jan; 33(1):75-79. PubMed ID: 34726639
[TBL] [Abstract][Full Text] [Related]
28. Quantitative Prediction of Human Renal Clearance and Drug-Drug Interactions of Organic Anion Transporter Substrates Using In Vitro Transport Data: A Relative Activity Factor Approach.
Mathialagan S; Piotrowski MA; Tess DA; Feng B; Litchfield J; Varma MV
Drug Metab Dispos; 2017 Apr; 45(4):409-417. PubMed ID: 28179375
[TBL] [Abstract][Full Text] [Related]
29. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
[TBL] [Abstract][Full Text] [Related]
30. Effect of probenecid on blood levels and renal elimination of furosemide and endogenous compounds in rats: Discovery of putative organic anion transporter biomarkers.
Thakur A; Saradhi Mettu V; Singh DK; Prasad B
Biochem Pharmacol; 2023 Dec; 218():115867. PubMed ID: 37866801
[TBL] [Abstract][Full Text] [Related]
31. Influence of the OATP Polymorphism on the Population Pharmacokinetics of Methotrexate in Chinese Patients.
Wang Z; Zhang N; Chen C; Chen S; Xu J; Zhou Y; Zhao X; Cui Y
Curr Drug Metab; 2019; 20(7):592-600. PubMed ID: 31267867
[TBL] [Abstract][Full Text] [Related]
32. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
[TBL] [Abstract][Full Text] [Related]
33. Gut-derived uremic toxin handling in vivo requires OAT-mediated tubular secretion in chronic kidney disease.
Bush KT; Singh P; Nigam SK
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32271169
[TBL] [Abstract][Full Text] [Related]
34. A Clinical Drug-Drug Interaction Study Assessing a Novel Drug Transporter Phenotyping Cocktail With Adefovir, Sitagliptin, Metformin, Pitavastatin, and Digoxin.
Trueck C; Hsin CH; Scherf-Clavel O; Schaeffeler E; Lenssen R; Gazzaz M; Gersie M; Taubert M; Quasdorff M; Schwab M; Kinzig M; Sörgel F; Stoffel MS; Fuhr U
Clin Pharmacol Ther; 2019 Dec; 106(6):1398-1407. PubMed ID: 31247117
[TBL] [Abstract][Full Text] [Related]
35. Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3.
Huang C; Xia F; Xue L; Liu L; Bian Y; Jin Z; Miao L
Cancer Chemother Pharmacol; 2020 Feb; 85(2):433-441. PubMed ID: 31691080
[TBL] [Abstract][Full Text] [Related]
36. Effects of two functionally important SLCO1B1 gene polymorphisms on pharmacokinetics of atorvastatin.
Rajput TA; Naveed AK; Farooqi ZR; Khan S
Pak J Pharm Sci; 2017 Jul; 30(4):1363-1370. PubMed ID: 29039339
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats.
Schneider R; Sauvant C; Betz B; Otremba M; Fischer D; Holzinger H; Wanner C; Galle J; Gekle M
Am J Physiol Renal Physiol; 2007 May; 292(5):F1599-605. PubMed ID: 17244891
[TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma.
Hegyi M; Arany A; Semsei AF; Csordas K; Eipel O; Gezsi A; Kutszegi N; Csoka M; Muller J; Erdelyi DJ; Antal P; Szalai C; Kovacs GT
Oncotarget; 2017 Feb; 8(6):9388-9398. PubMed ID: 27566582
[TBL] [Abstract][Full Text] [Related]
39. Differential Interaction of Dantrolene, Glafenine, Nalidixic Acid, and Prazosin with Human Organic Anion Transporters 1 and 3.
Burckhardt BC; Henjakovic M; Hagos Y; Burckhardt G
J Pharmacol Exp Ther; 2017 Sep; 362(3):450-458. PubMed ID: 28630284
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans.
Maeda K; Tian Y; Fujita T; Ikeda Y; Kumagai Y; Kondo T; Tanabe K; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Eur J Pharm Sci; 2014 Aug; 59():94-103. PubMed ID: 24747579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]